Prospective use of RFLP analysis on amplified Cryptococcus neoformans URA5 gene sequences for rapid identification of varieties and serotypes in clinical samples

Medical Mycology

Volumn 39, Issue 5, 2001, Pages 409-417

  Velegraki, A ^a   Kiosses, V G ^b   Kansouzidou, A ^c   Smilakou, S ^a   Mitroussia Ziouva, A ^a   Legakis, N J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^c Infectious Diseases Hospital of Thessaloniki   (Greece)

Author keywords

C. neoformans; PCR diagnosis; Serotyping

Indexed keywords

CETRIMIDE;

ARTICLE; BLOOD; CEREBROSPINAL FLUID; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC PROCEDURE; DIFFERENTIATION; DNA SYNTHESIS; EPIDEMIOLOGICAL DATA; FUNGAL GENETICS; FUNGUS IDENTIFICATION; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; ISOLATION PROCEDURE; LATEX AGGLUTINATION TEST; LUNG LAVAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY; SEROTYPING;

BASE SEQUENCE; CRYPTOCOCCUS NEOFORMANS; DNA, FUNGAL; GENES, FUNGAL; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; SEROTYPING;

EID: 0035152552     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.39.5.409.417     Document Type: Article

References (35)

1. Epidemiological survey on cryptococcosis in Europe. Notes for participants
2. Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in an immunocompetent host
3. The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis
4. Cryptococcus neoformans var. grubii: Separate varietal status for Cryptococcus neoformans serotype A isolates
5. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype AD
6. The green colour effect (GCE) of the killer strain Cryptococcus laurentii CBS 139 on Staib agar
7. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide
8. Identification by polymerase chain reaction fingerprinting of Cryptococcus neoformans serotype AD
9. Genetic relationship between Cryptococcus neoformans var. neoformans strains of serotypes A and D
10. The association between cryptococcal variety and immunocompetent and immunocompromised hosts
11. Detection of Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection
12. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release
13. Disseminated cryptococcosis without cryptococcal antigen detection
14. Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis
15. Hybridization probes for conventional DNA fingerprinting
16. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay
17. Differential killer toxin sensitivity patterns of varieties of Cryptococcus neoformans
18. Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents
19. New PCR primer pairs specific for Cryptococcus neoformans serotype A or B prepared on the basis of random amplified polymorphic DNA fingerprint pattern analysis
20. Concordance of clinical and environmental of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting
21. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA - A pilot study to standardize techniques on which to base a detailed epidemiological survey
22. Rapid extraction of fungal DNA from clinical samples for PCR amplification
23. Identification of fungal genera by polymerase chain reaction followed by restriction enzyme analysis
24. Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated with random amplification of polymorphic DNA fingerprinting
25. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis
26. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice
27. The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays
28. Protective murine monoclonal antibodies to Cryptococcus neoformans
29. Isolates of Cryptococcus neoformans serotype A and D developed on canavanine-glycine-bromothymol blue medium
30. Molecular analysis of CAP 59 gene sequences from five serotypes of Cryptococcus neoformans
31. Cryptococcal disease of the CNS in immunocompetent hosts: Influence of cryptococcal variety on clinical manifestations and outcome
32. Extensive allelic variation in Cryptococcus neoformans
33. Interstrain variation in deoxynucleotide composition of Cryptococcus neoformans: Nucleotide composition of Cryptococcus neoformans
34. Genetic relatedness of Cryptococcus neoformans clinical isolates grouped with the repetitive DNA probe CNRE-1